Bridget Flavin,
Adjunct Associate Instructional Professor
Department:
Pharmaceutical Outcomes & Policy
Business Email:
flavin.bridget@ufl.edu
About Bridget Flavin
Teaching Profile
Courses Taught
2022-2024
PHA6211 Applied Pharmacy Benefit Design
2023-2024
PHA6935 Selected Topics in Pharmacy
2024
PHA6041 Principles of Peer-Reviewed Biomedical Publications
Publications
Academic Articles
2024
Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program.
Journal of managed care & specialty pharmacy.
30(11-a Suppl):S1-S9
[DOI] 10.18553/jmcp.2024.30.11-a.s1.
[PMID] 39475629.
2022
Advancing a managed care pharmacy research agenda: Generating real-world evidence to support US Food and Drug Administration Accelerated Approvals and improving benefit design to address health inequities.
Journal of managed care & specialty pharmacy.
28(8):911-917
[DOI] 10.18553/jmcp.2022.22049.
[PMID] 35722828.
2022
AMCP Partnership Forum: The evolving role of digital therapeutics.
Journal of managed care & specialty pharmacy.
28(7):804-810
[DOI] 10.18553/jmcp.2022.22093.
[PMID] 35699389.
2022
Chronic graft-vs-host disease: Current understanding of disease and treatment landscape.
Journal of managed care & specialty pharmacy.
28(12-b Suppl):S2-S12
[DOI] 10.18553/jmcp.2022.28.12-b.s1.
[PMID] 36427348.
2022
Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States.
Expert opinion on drug safety.
21(2):167-170
[DOI] 10.1080/14740338.2022.2020244.
[PMID] 34915789.
2021
A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists
Diabetes Research and Clinical Practice.
175
[DOI] 10.1016/j.diabres.2021.108800.
2021
AMCP Partnership Forum: Biosimilars—policy, practice, and postmarketing surveillance to support treatment and coverage decisions
Journal of Managed Care & Specialty Pharmacy.
1-6
[DOI] 10.18553/jmcp.2021.21103.
2021
AMCP Partnership Forum: Helping patients anticipate and manage drug costs.
Journal of managed care & specialty pharmacy.
27(1):127-132
[DOI] 10.18553/jmcp.2020.20239.
[PMID] 33283615.
2021
AMCP Partnership Forum: Preparing for and managing rare diseases.
Journal of managed care & specialty pharmacy.
27(3):415-420
[DOI] 10.18553/jmcp.2021.20546.
[PMID] 33538235.
2021
AMCP Partnership Forum: Racial health disparities—a closer look at benefit design
Journal of Managed Care & Specialty Pharmacy.
1-7
[DOI] 10.18553/jmcp.2021.21217.
2021
Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries
Future Oncology.
[DOI] 10.2217/fon-2021-0607.
2014
Measuring economic impact of applying daily average consumption limits.
Journal of managed care pharmacy : JMCP.
20(2):159-64
[DOI] 10.18553/jmcp.2014.20.2.159.
[PMID] 24456317.
Education
PGY1 Managed Care Residency
2011-2012
·
RegenceRx, Portland, Oregon
Doctor of Pharmacy
2011
·
University of Missouri – Kansas City
Bachelor of Science, Biology
2004
·
University of Missouri – St. Louis
Minor, Chemistry
2004
·
University of Missouri – St. Louis
Contact Details
Emails:
- Business:
- flavin.bridget@ufl.edu
Addresses: